According to a market report by Lucintel, the future of the global next generation cancer diagnostics market looks promising with opportunities in the biomarker development, CTC analysis, proteomic analysis, epigenetic analysis, and genetic analysis markets. The global next generation cancer diagnostics market is expected to reach an estimated $17.
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to Reach $18.1 billion by 2030
According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 from $13.5 billion in 2024, at a CAGR o
Lucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 billion by 2030
According to a market report by Lucintel, the future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.3 billion by 2030 from $1.5 billion in 2024, a
Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 billion by 2030
According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. Th
Lucintel Forecasts the Global Colon Cancer Molecular Diagnostics Market is expected to grow with a CAGR of 7.8% from 2025 to 2031
According to a market report by Lucintel, the future of the global colon cancer molecular diagnostics market looks promising with opportunities in the clinical diagnosis, drug screening, and research markets. The global colon cancer molecular diagnostics market is expected to grow with a CAGR of 7.8% from 2025 to 2031. The major drivers for this ma